Septerna (SEPN) Return on Capital Employed (2024 - 2026)

Septerna (SEPN) recorded quarterly Return on Capital Employed of 0.47% in Q1 2026, up 123.32% quarter-over-quarter from 1.99% in Q4 2025, and up 2146.0% on a YoY basis from 0.02% in Q1 2025.

Septerna (SEPN) Return on Capital Employed (2024 - 2026) Analysis & Trends

Septerna's Return on Capital Employed history runs 3 years deep, the most recent figure standing at 0.47% for Q1 2026.

  • In Q1 2026, Return on Capital Employed rose 2146.0% year-over-year to 0.47%; the TTM figure through Mar 2026 stood at 0.47% (up 2146.0% YoY), while the FY2025 annual figure was 2.34%, up 2644.0% from the prior year.
  • Return on Capital Employed was 0.47% for Q1 2026 at Septerna, up from 1.99% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.47% in Q1 2026 to a low of 26.71% in Q4 2024.
  • Historically, Return on Capital Employed has averaged 15.31% across 3 years, with a median of 19.33% in 2025.
  • The sharpest annual moves came in 2025 and 2026: Return on Capital Employed jumped 2472 bps in 2025, then soared 2146 bps in 2026.
  • A 3-year view of Return on Capital Employed shows it stood at 26.71% in 2024, then surged by 93 bps to 1.99% in 2025, then surged by 123 bps to 0.47% in 2026.
  • The last three Return on Capital Employed figures came in at 0.47% (Q1 2026), 1.99% (Q4 2025), and 17.67% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 450.31%
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 51.73%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -107.40%
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 21.10%
9 Abivax 91.96 Bn 91.96 Bn - -50.43%
10 Septerna 1.62 Bn 1.62 Bn - 0.47%

Historic Data

Download Data
DateValue
Mar 31, 2026 0.47%
Dec 31, 2025 -1.99%
Sep 30, 2025 -17.67%
Jun 30, 2025 -24.95%
Mar 31, 2025 -20.99%
Dec 31, 2024 -26.71%